60 Degrees Pharmaceuticals (SXTP) executive compensation, 2026 proxy

Geoffrey Dow, President and Chief Executive Officer, was paid $727,750 in 2025, up 125% from $323,425 the year before.

Filed
July 2, 2026
Annual meeting
August 5, 2026
Pay year
2025
Named executives
3
CEO total pay
$727,750+125% vs prior year
Dow option award
$477,7502025 compensation table
Miller total compensation
$283,2502025 compensation table
Landon total compensation
$311,7912025 compensation table
Dow option grant
26,250Granted January 2, 2025
Miller option grant
3,750Granted January 2, 2025
Landon cash bonus
$11,7912025 compensation table

How Dow was paid

$727,750 in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary34%Option awards66%

Named executive officers

ExecutiveTotal
Geoffrey DowPresident and Chief Executive Officer$727,750
Tyrone MillerChief Financial Officer$283,250
Kristen LandonChief Commercial Officer$311,791

What changed and why

  • $728K$727,750 was CEO Geoffrey Dow’s 2025 total compensation, compared with $323,425 in 2024.
  • $250K$250,000 was Dow’s 2025 base salary, increased from $228,000 in 2024.
  • $478K$477,750 was Dow’s 2025 option award value.
  • $283K$283,250 was CFO Tyrone Miller’s 2025 total compensation, compared with $284,525 in 2024.
  • $312K$311,791 was Chief Commercial Officer Kristen Landon’s 2025 total compensation, including an $11,791 cash bonus.
  • $26.2026,250 options were granted to Dow on January 2, 2025, with a $26.20 exercise price.

Other 60 Degrees Pharmaceuticals proxy statements

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.